Private Market View

Aktis Oncology

Drug Discovery · Boston, MA · Founded 2021 · Privately Held (backing)

PA Mark · $/share
$21
Sep 2026
Implied valuation
Total raised
$336.0M
Last round
Early Stage VC (Series B)
Sep 2024
Cap table — not yet on record

Aktis Oncology's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 23 names
  • ·Watchlist + deal alerts for Aktis Oncology
Create free account
No card required

Frequently asked

Where does Aktis Oncology's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Aktis Oncology's 1 recorded funding rounds.